Genetic Risk Score

BEHAVIORAL2 trials

Sponsors

Mayo Clinic, National University of Singapore

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseGenomic Risk CommunicationMyocardial Infarction

Unknown Phase

Myocardial Infarction Genes (MI-GENES) Study

CompletedNCT01936675

Mayo ClinicCoronary Artery Disease, Genomic Risk Communication, Myocardial Infarction

Start: 2013-07-31End: 2014-11-30Updated: 2016-05-03

HOPE-CVD-Virtual: A Virtual Trial to Evaluate the Primary Prevention of CVD

CompletedNCT05827861

National University of SingaporeCardiovascular Diseases

Start: 2023-05-15End: 2025-10-10Updated: 2026-04-27

Related Papers

Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events

Circulation Genomic and Precision Medicine2025-03-283 citations

Abstract 4140097: Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events: 10-year Follow-up of the MI-GENES Randomized Clinical Trial

Circulation2024-11-12

Electronic health record access by patients as an indicator of information seeking and sharing for cardiovascular health promotion in social networks: Secondary analysis of a randomized clinical trial

Preventive Medicine Reports2019-01-151 citations

Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing

Circulation Cardiovascular Genetics2017-08-0137 citations

Shared Decision-Making following Disclosure of Coronary Heart Disease Genetic Risk: Results from a Randomized Clinical Trial

Journal of Investigative Medicine2016-12-2428 citations

Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates

Circulation2016-02-26258 citations

Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study.

2015-08-1517 citations